ISSUES THAT PLAGUE NON- INFERIORITY TRIALS PAST AND FUTURE RALPH B. DAGOSTINO, SR. BOSTON UNIVERSITY HARVARD CLINICAL RESEARCH INSTITUTE.
Update On Antifungals,Grand Round
Statistical considerations Alfredo García – Arieta, PhD Training workshop: Training of BE assessors, Kiev, October 2009.
New Oral Anticoagulants (NOACs) Dabigatran and Rivaroxaban for the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation Dr Dipti.
Clinical Trials: How to do them? Basil S. Lewis, MD, FRCP, FACC, FESC Professor of Medicine Haifa, Israel Chairman-Elect, ESC WG on Cardiovascular Pharmacotherapy.
ASH Highlights, 2007: Lymphoma Lawrence D. Kaplan MD UCSF.
XELOX vs. FOLFOX4: survival and response results from XELOX-1 / NO16966, a randomized phase III trial of first-line treatment for patients with metastatic.
Dr Dipti Chitnavis / Dr Claire Hughes Consultants in Haematology West Suffolk Hospital
J. Matthew Brennan, MD, MPH Interventional Cardiology Duke University Medical Center
